Page last updated: 2024-10-21

aminopropionitrile and Hyperparathyroidism

aminopropionitrile has been researched along with Hyperparathyroidism in 1 studies

Aminopropionitrile: Reagent used as an intermediate in the manufacture of beta-alanine and pantothenic acid.

Hyperparathyroidism: A condition of abnormally elevated output of PARATHYROID HORMONE (or PTH) triggering responses that increase blood CALCIUM. It is characterized by HYPERCALCEMIA and BONE RESORPTION, eventually leading to bone diseases. PRIMARY HYPERPARATHYROIDISM is caused by parathyroid HYPERPLASIA or PARATHYROID NEOPLASMS. SECONDARY HYPERPARATHYROIDISM is increased PTH secretion in response to HYPOCALCEMIA, usually caused by chronic KIDNEY DISEASES.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rosenthall, L1
Kaye, M1

Other Studies

1 other study available for aminopropionitrile and Hyperparathyroidism

ArticleYear
Observations on the mechanism of 99mTc-labeled phosphate complex uptake in metabolic bone disease.
    Seminars in nuclear medicine, 1976, Volume: 6, Issue:1

    Topics: Aminopropionitrile; Animals; Bone and Bones; Chronic Kidney Disease-Mineral and Bone Disorder; Dipho

1976